Incentive drugs for substitute dispensing decline in January

Published: 2009-02-19 06:59:00

Updated: 2009-02-19 06:59:00

A total of 3,777 incentive drugs (including 155 control drugs), which have been endorsed by bioequivalence tests, are available for substitute dispensing as of January 31 this year, down 146 items compared with 3,923 items last October, according to data released by the Health Insurance Review an...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK